You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
老百姓(603883.SH)擬受讓藥聖堂科技公司100%股權並註銷藥聖堂製藥公司
格隆匯 12-30 22:42

格隆匯12月30日丨老百姓(603883.SH)公佈,公司擬受讓全資子公司藥聖堂(湖南)製藥有限公司(以下簡稱“藥聖堂製藥公司”)持有的湖南藥聖堂中藥科技有限公司(以下簡稱“藥聖堂科技公司”)100%股權並註銷藥聖堂製藥公司。

公司從事中藥生產的全資子公司藥聖堂製藥公司地處湖南省常德市安鄉縣,地理位置偏僻,吸引人才困難。為提升公司中藥生產專業能力和產能,公司於2015年10月,在湖南省長沙市芙蓉區隆平高科技園,通過藥聖堂製藥公司股權投資,設立了藥聖堂科技公司。該公司配備了現代化生產設備172台、公用設施設備62台套、檢測和研發設備143台,擁有中藥飲片產能6000噸/年,並於2018年11月通過GMP認證,正式投入生產。藥聖堂科技公司已承接藥聖堂製藥公司中藥生產能力,實現轉型升級,符合公司長期戰略規劃。

為進一步節約公司現有資源、優化公司業務結構和治理架構、降低企業管理成本、提高運營效率,改善整體經營質量,公司通過審慎考慮,決定受讓藥聖堂製藥公司全資子公司藥聖堂科技100%股權並註銷藥聖堂製藥公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account